Green Lipped Mussel vs Fish Oil: Which Is Better for Joint Health? (NZ Guide 2026)

If you're researching supplements for joint health, you've probably come across both green lipped mussel and fish oil. Both are linked to inflammation support. Both have real research behind them. So which one should you take? At Deep Blue Health, we sell both — so we have no interest in steering you one way. This guide breaks down the evidence honestly so you can make the right call for your situation.

What Is Green Lipped Mussel?

Green lipped mussel (Perna canaliculus) is a large shellfish found exclusively in the coastal waters of New Zealand. It has been a dietary staple for Māori communities for centuries — and some researchers have suggested that the historically low rates of joint conditions in coastal Māori populations may be partly linked to their high consumption of it.

What makes green lipped mussel genuinely different from fish oil is its compound profile. It doesn't just provide EPA and DHA. It also contains eicosatetraenoic acid (ETA), a rare omega-3 fatty acid found in very few other natural sources, which research suggests may inhibit both COX and LOX inflammatory enzymes. Alongside these lipids, it provides glycosaminoglycans (GAGs) — including chondroitin sulphate and glucosamine — which are the natural structural components of joint cartilage.

This combination of anti-inflammatory lipids and cartilage-building compounds is why green lipped mussel is studied specifically for joint conditions, rather than as a general anti-inflammatory supplement.

Deep Blue Health offers green lipped mussel in three formats:

• New Zealand Green Lipped Mussel Capsules — 100% pure NZ GLM powder, the most straightforward and affordable option
• GlycOmega-Plus — an 8:1 standardised GLM concentrate combined with rosemary extract, the most researched of our GLM products
• KUKU Mussel Oil — CO2-extracted mussel oil at the highest potency available, equivalent to 27,000mg of fresh mussel per capsule

All three are sourced from New Zealand mussel farms and cold-processed to preserve the full bioactive lipid profile.

What Is Fish Oil / Omega-3?

Fish oil is extracted from the tissue of oily marine fish — typically sardines, anchovies, and mackerel. It's one of the most studied nutritional supplements in the world, with hundreds of clinical trials examining its role in reducing systemic inflammation.

The primary active compounds are EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid). These omega-3 fatty acids help regulate the inflammatory response by influencing the production of prostaglandins, leukotrienes, and other chemical messengers that drive inflammation in joint tissue and throughout the body.

A noteworthy alternative to standard fish oil is krill oil — derived from Antarctic krill (Euphausia superba) rather than fish. Krill oil delivers omega-3 in phospholipid form, a structure closer to how omega-3 appears in human cell membranes. It also comes naturally bound with astaxanthin, a potent antioxidant that protects the fatty acids from oxidation.

Deep Blue Health's omega-3 product is Krill Oil, sourced from Antarctic krill. Each capsule provides 330mg of omega-3, including 180mg EPA and 90mg DHA, in phospholipid form. We don't stock a standard fish oil — krill oil is our preferred option based on the absorption and stability advantages.

How Do They Compare for Joint Health?

Active Compounds & Mechanism

Fish oil and green lipped mussel work through overlapping but distinct anti-inflammatory pathways. Fish oil primarily provides EPA and DHA, which the body converts into resolvins and protectins — pro-resolving mediators that help switch off the inflammatory response. Green lipped mussel does this too, but also contributes ETA, which research suggests may directly inhibit both COX and LOX inflammatory enzymes (Halpern, 2000). In addition, the GAG content in GLM acts as a structural input for joint cartilage — a mechanism fish oil simply doesn't have.

Bioavailability & Absorption

Standard fish oil delivers omega-3 in a triglyceride form that requires enzymatic conversion before the body can use it. Krill oil's phospholipid structure bypasses some of this process — a 2011 study by Schuchardt et al., published in Lipids in Health and Disease, found that phospholipid-form omega-3 showed improved incorporation into plasma phospholipids compared to triglyceride formulations. Green lipped mussel omega-3 is delivered within a complex lipid matrix alongside GAGs and glycoproteins, which may further support how it's processed — though direct bioavailability comparison data between GLM and fish oil remains limited.

Clinical Evidence for Joint Health

Both ingredients have credible clinical support. A 2007 meta-analysis by Goldberg and Katz, published in Pain, pooled results from 17 randomised controlled trials examining omega-3 supplementation in inflammatory joint conditions. It found statistically significant reductions in joint pain intensity and morning stiffness, with a good safety profile (Goldberg & Katz, 2007). For green lipped mussel, a University of Queensland clinical trial examining GlycOmega-Plus in osteoarthritis patients reported that approximately 59% of participants experienced meaningful relief — a notable result, though the overall evidence base for GLM remains smaller than for omega-3 fatty acids.

Sustainability & Sourcing

Green lipped mussel farming is widely regarded as one of the most environmentally responsible forms of aquaculture. New Zealand mussel farms require no feed inputs — the mussels filter-feed on naturally occurring phytoplankton — and are independently audited for ecological impact. Antarctic krill fishing is managed under the CCAMLR international quota system, which enforces strict catch limits to protect the Southern Ocean ecosystem. Both represent responsible sourcing relative to bulk fish oil from open-ocean industrial trawling.

Who Each Suits Best

Green lipped mussel is typically better suited to people whose primary concern is joint-specific — particularly osteoarthritis, joint stiffness, or age-related cartilage wear. The GAG component gives it a structural advantage that fish oil doesn't replicate. Omega-3 (from krill oil or fish oil) is the stronger choice when cardiovascular health and broader systemic inflammation are the priority, with joint support as a secondary benefit.

What Does the Research Say?

A 2007 meta-analysis by Goldberg and Katz, published in Pain, analysed 17 randomised controlled trials on omega-3 supplementation in patients with inflammatory joint conditions. It found statistically significant reductions in joint pain intensity and morning stiffness, and noted that omega-3 supplementation allowed some patients to reduce their NSAID use (Goldberg & Katz, 2007).

A University of Queensland clinical trial examining GlycOmega-Plus in osteoarthritis patients reported improvement in approximately 59% of participants, with improvements in pain scores and joint mobility observed over the course of the trial.

A 2013 review by Calder, published in the Biochemical Society Transactions, examined the mechanisms by which EPA and DHA resolve — not merely suppress — inflammatory processes through the production of specialised pro-resolving mediators including resolvins, protectins, and maresins. This is relevant to understanding why consistent long-term omega-3 use may have broader benefits beyond short-term symptom relief (Calder, 2013).

Research by Halpern (2000), published in Allerg Immunol (Paris), examined the anti-inflammatory lipid profile of stabilised Perna canaliculus extract and suggested that ETA may act as a dual COX/LOX inhibitor — a mechanism that, if replicated in larger trials, would distinguish GLM significantly from standard omega-3 supplementation.

It's worth noting that the overall body of clinical evidence for green lipped mussel is smaller than for fish oil omega-3. Both have promising research — but neither should be treated as a substitute for medical advice or prescribed treatment for diagnosed joint conditions.

Can You Take Both Together?

Yes — and for many people, this is the most effective approach. Green lipped mussel and omega-3 work through complementary pathways rather than competing ones. GLM contributes the full lipid complex including ETA and GAGs, while krill oil adds volume EPA and DHA in a highly absorbable form. Combining them means you're covering both the structural support pathway (GAGs contributing to cartilage maintenance) and the systemic anti-inflammatory pathway (EPA/DHA producing resolvins and protectins) simultaneously.

There are no known negative interactions between green lipped mussel and krill oil or fish oil. The most common combination among Deep Blue Health customers focused on joint and inflammation support is GlycOmega-Plus alongside Krill Oil. If you're on blood-thinning medication, speak with your GP before adding high-dose omega-3 to your routine.

Which Should You Choose?

• If joint mobility and cartilage health is your primary concern — particularly osteoarthritis, joint stiffness, or years of physical wear — start with green lipped mussel. GlycOmega-Plus is the most researched option. The GAG content gives it a structural advantage that omega-3 alone can't match.
• If cardiovascular health and broad anti-inflammatory support is your priority — with joint support as a secondary benefit — Krill Oil is the more direct fit.
• If you want comprehensive joint and anti-inflammatory coverage — consider both. GlycOmega-Plus for the full GLM lipid complex, Krill Oil for concentrated EPA and DHA. This combination addresses multiple pathways and is the approach we'd recommend for anyone with an active joint condition.

As always, if you have a diagnosed joint condition or are currently taking prescribed medication, speak with your GP or health professional before starting any new supplement.

Frequently Asked Questions

Is green lipped mussel better than fish oil for arthritis?

It depends on the type of arthritis. For osteoarthritis — the most common form, involving cartilage wear — green lipped mussel is often preferred because it provides glycosaminoglycans (GAGs), the structural building blocks of cartilage, alongside anti-inflammatory lipids. For rheumatoid arthritis, omega-3 fatty acids (EPA and DHA) have a stronger meta-analysis evidence base for reducing joint pain and morning stiffness. A health professional who knows your history is the best guide.

How long does green lipped mussel take to work compared to fish oil?

Both supplements typically require 4–8 weeks of consistent daily use before noticeable effects. Green lipped mussel and omega-3 both work through gradual modulation of inflammatory pathways — they are not fast-acting pain relievers. Consistency is more important than dose size. If you haven't noticed improvement after 8–10 weeks at the recommended dose, speak with a health professional.

Can I take green lipped mussel and fish oil at the same time?

Yes. There are no known negative interactions between green lipped mussel and fish oil or krill oil supplements. They work through complementary anti-inflammatory mechanisms, so taking both is a common approach for comprehensive joint and inflammation support. Those on anticoagulant medications should check with their GP before combining them with high-dose omega-3.

Shop Deep Blue Health

For green lipped mussel, GlycOmega-Plus is our most researched option, or try our New Zealand Green Lipped Mussel Capsules as an affordable starting point. For omega-3, our Krill Oil is our most popular choice — Antarctic-sourced, phospholipid form, with naturally occurring astaxanthin. All Deep Blue Health products are quality tested and New Zealand formulated.

References

• Goldberg, R.J., & Katz, J. (2007). A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain, 129(1–2), 210–223. doi:10.1016/j.pain.2007.01.020
• Calder, P.C. (2013). Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Biochemical Society Transactions, 41(6), 1471–1476. doi:10.1042/BST20130147
• Schuchardt, J.P., et al. (2011). Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations. Lipids in Health and Disease, 10(1), 145. doi:10.1186/1476-511X-10-145
• Halpern, G.M. (2000). Anti-inflammatory effects of a stabilized lipid extract of Perna canaliculus (Lyprinol). Allerg Immunol (Paris), 32(7), 272–278.
• University of Queensland Clinical Trial — GlycOmega-Plus osteoarthritis study (results referenced in GlycOmega-Plus product documentation).